Literature DB >> 638387

Immunoglobulins and viral antibodies in psychiatric patients.

E F Toorey, M R Peterson, W L Brannon, W T Carpenter, R M Post, D P Van Kammen.   

Abstract

The serum and CSF of 66 patients with functional psychoses were tested for immunoglobulins and antibodies to measles, HSV-I, CMV, and rubella viruses. Ten surgical and 80 neurological patients were controls. There were no significant findings in the serum, consistent with most previous studied. In the CSF 6 of 17 multiple admission schizophrenic patients had definite elevations of IgG or measles antibody and differed significantly from the surgical controls. Immunologically this group resembled the seriously ill neurological patients. No previous study has been made of immunoglobulins or viral antibodies in the CSF of psychiatric patients. It is concluded that further work is warranted in a search for biological subgroups of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638387     DOI: 10.1192/bjp.132.4.342

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  9 in total

Review 1.  Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?

Authors:  Nenad Vasic; Bernhard J Connemann; Robert C Wolf; Hayrettin Tumani; Johannes Brettschneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-16       Impact factor: 5.270

2.  Blood-cerebrospinal fluid barrier in schizophrenic patients.

Authors:  K Bauer; J Kornhuber
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

3.  Deficient natural killer cell (NK) activity and macrophage functioning in schizophrenic patients.

Authors:  L E DeLisi; J R Ortaldo; A E Maluish; R J Wyatt
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

Review 4.  Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.

Authors:  Barbara Sperner-Unterweger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  Viruses, schizophrenia, and bipolar disorder.

Authors:  R H Yolken; E F Torrey
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

6.  The acute periventricular injury syndrome: a possible animal model for psychotic disease.

Authors:  J Kline; K H Reid
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent Toxoplasma Gondii infection.

Authors:  Nora Hamdani; Djaouida Bengoufa; Ophélia Godin; Raphaël Doukhan; Emmanuel Le Guen; Claire Daban-Huard; Meriem Bennabi; Marine Delavest; Jean-Pierre Lépine; Wahid Boukouaci; Hakim Laouamri; Josselin Houenou; Stéphane Jamain; Jean-Romain Richard; Philippe Lecorvosier; Robert Yolken; Krishnamoorthy Rajagopal; Marion Leboyer; Ryad Tamouza
Journal:  BMC Psychiatry       Date:  2018-07-27       Impact factor: 3.630

8.  Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.

Authors:  Sonja Orlovska-Waast; Ole Köhler-Forsberg; Sophie Wiben Brix; Merete Nordentoft; Daniel Kondziella; Jesper Krogh; Michael Eriksen Benros
Journal:  Mol Psychiatry       Date:  2018-08-16       Impact factor: 15.992

9.  Antibody indices of infectious pathogens from serum and cerebrospinal fluid in patients with schizophrenia spectrum disorders.

Authors:  Ludger Tebartz van Elst; Dominique Endres; Kimon Runge; Agnes Balla; Bernd L Fiebich; Simon J Maier; Benjamin Pankratz; Andrea Schlump; Kathrin Nickel; Rick Dersch; Katharina Domschke
Journal:  Fluids Barriers CNS       Date:  2022-07-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.